⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL757240 | 0.78 | — | — | |
| SCHEMBL8874121 | 0.78 | — | — | |
| SCHEMBL757239 | 0.78 | — | — | |
| SCHEMBL4135528 | 0.78 | — | — | |
| SCHEMBL1132105 | 0.76 | — | — | |
| SCHEMBL5138836 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL1825390 | 0.76 | CETP (0.43) | — | |
| SCHEMBL29512386 | 0.76 | GABRR1 (0.36) | — | |
| SCHEMBL21199073 | 0.72 | CETP (0.40) | — | |
| SCHEMBL1132763 | 0.72 | GABRR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110869374-B | 2-oxo-1, 3-oxazolidinyl imidazothiadiazole derivatives | UCB生物制药有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-110869375-B | 2-oxo-1-imidazolidinylimidazothiadiazole derivatives | UCB生物制药有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11155565-B2 | 2-oxo-1,3-oxazolidinyl imidazothiadiazole derivatives | UCB Biopharma SRL | 2021-10-26 | — | — | US | disclosed |
| EP-3652183-B1 | 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | UCB Biopharma SRL (BE) | 2021-09-08 | — | — | EP | disclosed |
| EP-3652182-B1 | 2-OXO-1-IMIDAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | UCB Biopharma SRL (BE) | 2021-09-08 | — | — | EP | disclosed |
| US-20200231599-A1 | 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | UCB BIOPHARMA SPRL (BE) | 2020-07-23 | — | — | US | disclosed |
| WO-2019011770-A1 | 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | UCB BIOPHARMA SPRL (BE) | 2019-01-17 | — | — | WO | disclosed |